Thyroseq V3 molecular testing for fine needle aspiration biopsy samples of thyroid nodules

The National Institutes of Health (NIH) is seeking a contractor to provide Thyroseq V3 molecular testing for fine needle aspiration biopsy samples of thyroid nodules. The contractor will be responsible for testing up to 20 thyroid nodules per year and providing detailed reports on the identified mutations and corresponding risk for malignancy. The contractor must also provide sample collection and storage equipment at no additional cost to the NIH. The contract will be awarded based on the Lowest Price Technically Acceptable (LPTA) evaluation criteria. • The contractor must provide next-generation molecular testing for fine needle aspiration biopsy samples of thyroid nodules. • The contractor must test for about 110 thyroid cancer-related genes in indeterminate thyroid nodule fine needle aspiration biopsy samples. • The contractor must provide a detailed report on the identified mutations and corresponding risk for malignancy. • The contractor must provide sample collection and storage equipment at no additional cost to the NIH.